Literature DB >> 31040170

Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus.

Agnieszka Kapłon-Cieślicka1, Monika Budnik1, Monika Gawałko1, Michał Peller1, Iwona Gorczyca2, Anna Michalska2, Aldona Babiarz1, Aleksandra Bodys1, Robert Uliński1, Maciej Żochowski1, Piotr Scisło1, Janusz Kochanowski1, Krzysztof J Filipiak1, Grzegorz Opolski1.   

Abstract

OBJECTIVE: We aimed to identify predictors of left atrial appendage (LAA) thrombus in patients with atrial fibrillation (AF) and to enhance the prognostic value of the CHA2DS2-VASc score.
METHODS: Derivation cohort included 1033 consecutive AF patients referred for catheter ablation or direct current cardioversion, in whom transoesophageal echocardiography (TOE) was performed prior to the procedure. Logistic regression analysis was used to identify predictors of LAA thrombus on TOE. Receiver operating characteristic (ROC) curves were constructed to compare the newly developed score with the CHA2DS2 and CHA2DS2-VASc scores in the derivation and the validation (n=320) cohort.
RESULTS: On TOE, LAA thrombus was present in 59 (5.7%) patients in the derivation cohort. Aside from variables encompassed by the CHA2DS2-VASc score, LAA thrombus predictors included AF type (persistent/'permanent' vs paroxysmal) and renal dysfunction. These predictors were incorporated into the CHA2DS2-VASc score. In ROC analysis, area under the curve (AUC) for the new score (CHA2DS2-VASc-RAF score) was significantly higher (0.81) than those for the CHA2DS2 and CHA2DS2-VASc scores (0.71 and 0.70, respectively). In the validation cohort, the CHA2DS2-VASc-RAF score also performed significantly better (AUC of 0.88) than the CHA2DS2 and CHA2DS2-VASc scores (AUC of 0.63 and 0.60, respectively).
CONCLUSION: In real-world AF patients with majority on oral anticoagulation, LAA thrombus was found in approximately 6%. Two variables not included in the CHA2DS2-VASc score (AF type and renal dysfunction) proved strong, independent predictors of LAA thrombus and might improve thromboembolic risk stratification. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  atrial fibrillation; cardiac risk factors and prevention

Year:  2019        PMID: 31040170     DOI: 10.1136/heartjnl-2018-314492

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  17 in total

1.  Prevalence and risk factors of left atrial thrombus in patients with atrial fibrillation and lower class (IIa) recommendation to anticoagulants.

Authors:  Beata Uziębło-Życzkowska; Paweł Krzesiński; Agnieszka Jurek; Monika Budnik; Iwona Gorczyca; Agnieszka Kapłon-Cieślicka; Marek Kiliszek; Agnieszka Wójcik; Monika Gawałko; Olga Jelonek; Anna Michalska; Katarzyna Starzyk; Piotr Scisło; Janusz Kochanowski; Krzysztof J Filipiak; Beata Wożakowska-Kapłon; Grzegorz Opolski; Grzegorz Gielerak
Journal:  Cardiovasc Diagn Ther       Date:  2020-08

2.  External validation and comparison of CHA2DS2-VASc-RAF and CHA2DS2-VASc-LAF scores for predicting left atrial thrombus and spontaneous echo contrast in patients with non-valvular atrial fibrillation.

Authors:  Nan Zheng; Jun Zhang
Journal:  J Interv Card Electrophysiol       Date:  2022-07-13       Impact factor: 1.759

3.  Prediction model based on machine learning for short- and long-term adverse events in left atrial appendage closure.

Authors:  Xiaogang Zhang; Bei Tian; Xinpeng Cong; Shu-Wen Hao; Qiang Huan; Can Jin; Luoning Zhu; Zhong-Ping Ning
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

4.  Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry.

Authors:  Iwona Gorczyca; Olga Jelonek; Beata Uziębło-Życzkowska; Magdalena Chrapek; Małgorzata Maciorowska; Maciej Wójcik; Robert Błaszczyk; Agnieszka Kapłon-Cieślicka; Monika Gawałko; Monika Budnik; Tomasz Tokarek; Renata Rajtar-Salwa; Jacek Bil; Michał Wojewódzki; Anna Szpotowicz; Janusz Bednarski; Elwira Bakuła-Ostalska; Anna Tomaszuk-Kazberuk; Anna Szyszkowska; Marcin Wełnicki; Artur Mamcarz; Beata Wożakowska-Kapłon
Journal:  J Clin Med       Date:  2020-11-05       Impact factor: 4.241

5.  Clinical prediction scores and early anticoagulation therapy for new-onset atrial fibrillation in critical illness: a post-hoc analysis.

Authors:  Masaaki Sakuraya; Takuo Yoshida; Yusuke Sasabuchi; Shodai Yoshihiro; Shigehiko Uchino
Journal:  BMC Cardiovasc Disord       Date:  2021-09-08       Impact factor: 2.298

6.  Refinement of CHADS2 and CHA2DS2-VASc scores predict left atrial thrombus or spontaneous echo contrast in nonvalvular atrial fibrillation patients.

Authors:  Miaomiao Cao; Huihui Guo; Xiao Zhao; Xiyang Li; Chaofeng Sun
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

7.  Relations between left atrial appendage contrast retention and thromboembolic risk in patients with atrial fibrillation.

Authors:  Xu Lu; Tao Chen; Ge Liu; Yutao Guo; Xiangmin Shi; Yundai Chen; Yang Li; Jun Guo
Journal:  J Thromb Thrombolysis       Date:  2021-06-15       Impact factor: 2.300

8.  Left Ventricular Ejection Fraction Is Associated with the Risk of Thrombus in the Left Atrial Appendage in Patients with Atrial Fibrillation.

Authors:  Beata Uziębło-Życzkowska; Paweł Krzesiński; Agnieszka Jurek; Agnieszka Kapłon-Cieślicka; Iwona Gorczyca; Monika Budnik; Grzegorz Gielerak; Marek Kiliszek; Monika Gawałko; Piotr Scisło; Janusz Kochanowski; Olga Jelonek; Anna Michalska; Katarzyna Starzyk; Krzysztof J Filipiak; Beata Wożakowska-Kapłon; Grzegorz Opolski
Journal:  Cardiovasc Ther       Date:  2020-04-24       Impact factor: 3.023

9.  Does the CHA2DS2-VASc scale sufficiently predict the risk of left atrial appendage thrombus in patients with diagnosed atrial fibrillation treated with non-vitamin K oral anticoagulants?

Authors:  Anna Michalska; Iwona Gorczyca; Magdalena Chrapek; Agnieszka Kapłon-Cieślicka; Beata Uziębło-Życzkowska; Katarzyna Starzyk; Olga Jelonek; Monika Budnik; Monika Gawałko; Paweł Krzesiński; Agnieszka Jurek; Piotr Scisło; Janusz Kochanowski; Marek Kiliszek; Grzegorz Gielerak; Krzysztof J Filipiak; Grzegorz Opolski; Beata Wożakowska-Kapłon
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

10.  CHA2DS2-VASc Score as a Predictor for Left Atrial Thrombus or Spontaneous Echo Contrast in Patients with Nonvalvular Atrial Fibrillation: A Meta-Analysis.

Authors:  Ping Sun; Zhi Hao Guo; Hong Bin Zhang
Journal:  Biomed Res Int       Date:  2020-07-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.